RayzeBio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2022 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: RayzeBio, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q3 2023.
RayzeBio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $2.56M, a 77.2% increase year-over-year.

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023		$2.56M	+$1.12M	+77.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q3 2022		$1.45M			Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.